List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 179 studies with search of: patients at high risk for cardiovascular events
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed
Has Results 		Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
2 Active, not recruiting Periodontitis and Cardiovascular Events or "PAVE"
Conditions: Cardiovascular Disease;   Coronary Heart Disease;   Myocardial Infarction;   Cerebrovascular Accident
Intervention: Procedure: Treatment of periodontal infections (gum problems)
3 Completed Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
Condition: Hypercholesteremia
Intervention:
4 Recruiting PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Conditions: Brain Ischemia;   Intracranial Hemorrhages
Interventions: Drug: Cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: placebo of aspirin;   Device: ankle-brachial index (ABI);   Device: intima-medial thickness (IMT);   Device: new asymptomatic brain hemorrhage;   Device: new ischemic lesions on follow-up FLAIR images
5 Active, not recruiting Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
Conditions: Hypertension;   Cardiovascular Diseases
Intervention: Drug: Candesartan cilexetil
6 Recruiting Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
Conditions: Acute Myocardial Infarction;   Angina Pectoris;   Myocardial Ischemia;   Acute Coronary Syndrome;   Hypertension
Interventions: Drug: Micardis (Telmisartan);   Drug: Blopress (Candesartan)
7 Active, not recruiting Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.
Condition: Congestive Heart Failure
Interventions: Other: Drug therapy for HF;   Other: NT-proBNP guided HF therapy
8 Active, not recruiting OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
Conditions: Hypertension;   Cardiovascular Diseases
Interventions: Drug: Olmesartan medoxomil;   Drug: Calcium channel blockers (amlodipine, azelnidipine)
9 Completed Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension: ACCOMPLISH
Condition: Hypertension
Intervention: Drug: Benazepril/amlodipine
10 Active, not recruiting Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
Conditions: Hypertension;   Cardiovascular Disease;   Diabetes
Interventions: Drug: olmesartan medoxomil / amlodipine or azelnidipine;   Drug: olmesartan medoxomil / low dose thiazide type drug
11 Completed Heart Rate Variability for Prediction of Perioperative Events
Conditions: Anesthesia;   Coronary Heart Disease
Intervention: Device: Heart Rate Variability analysis
12 Completed Ramipril 10 mg/Day Prevention
Condition: Atherosclerosis
Intervention: Drug: Ramipril
13 Recruiting Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
Condition: Diabetes
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Benazepril/Valsartan
14 Completed Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients
Conditions: Chronic Renal Failure;   Hemodialysis;   Atherosclerosis
Intervention:
15 Completed Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Perindopril-indapamide;   Drug: Gliclazide MR-based glucose lowering
16 Recruiting Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Aliskiren;   Drug: Placebo
17 Completed FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR ® (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.
Condition: Heart Failure, Congestive
Intervention: Drug: nesiritide
18 Recruiting Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients
Condition: Essential Hypertension
Intervention: Drug: Amlodipine, Telmisartan, compound Amiloride, Simvastatin
19 Completed S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: indobufen;   Drug: aspirin
20 Recruiting Preventing Microalbuminuria in Type 2 Diabetes
Condition: Diabetes
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Benazepril/Valsartan

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services